Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
22 studies found for:    "Benign Breast Disease"
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease
Condition: Breast Fibrocystic Disease
Interventions: Dietary Supplement: Oncoxin;   Dietary Supplement: Placebo
2 Completed A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease
Condition: Fibrocystic Disease of Breast
Interventions: Drug: danazol;   Drug: Placebo
3 Completed
Has Results
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
Conditions: Benign Breast Disease;   Fibrocystic Disease of Breast;   Fibroadenoma;   Mastalgia
Interventions: Drug: Tamoxifen;   Drug: Evening Primrose Oil
4 Enrolling by invitation VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue
Condition: Benign Breast Disease
Interventions: Dietary Supplement: Vitamin D and fish oil placebo;   Dietary Supplement: Fish oil and vitamin D placebo;   Dietary Supplement: Vitamin D placebo and fish oil placebo;   Dietary Supplement: Vitamin D and fish oil
5 Completed Genetics of Mammographic Appearances and Patterns (The GenMap Study)
Condition: Benign Breast Disease
6 Completed Nuclear Morphology of Breast Cells in Ductal Lavage
Condition: Benign Breast Disease
Intervention: Procedure: breast ductal lavage
7 Unknown  China CellSearch Study
Conditions: Metastatic Breast Cancer;   Benign Breast Disease
8 Completed Prolactin Receptor and Breast Diseases
Conditions: Benign Breast Disease;   Breast Cancer
Interventions: Biological: blood collection for hormonal status analysis;   Procedure: breast Biopsy or surgery;   Genetic: blood collection;   Other: ultrasonography (pelvis and breast), bone mineral density
9 Active, not recruiting A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness
Condition: Fibrocystic Breast Condition (FBC)
Interventions: Dietary Supplement: Violet™ Molecular Iodine (I2);   Other: Placebo
10 Recruiting Johns Hopkins Breast Cancer Program Longitudinal Repository
Conditions: Breast Cancer;   Benign Breast Disease
Intervention: Procedure: Sample collection
11 Not yet recruiting Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)
Condition: Breast Cancer
Intervention: Drug: Definity
12 Recruiting A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule
Condition: Fibrocystic Disease of Breast
Interventions: Drug: Xiaoru Sanjie capsules;   Drug: Xiao Yao pills
13 Unknown  Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain
Conditions: Fibrocystic Disease of Breast;   Fibrocystic Changes of Breast;   Fibrocystic Mastopathy;   Pain
Intervention: Drug: IoGen (molecular iodine)
14 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
15 Completed A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses
Conditions: Fibrocystic Disease of Breast;   Breast Cancer
Intervention: Device: Digital Breast Tomosynthesis
16 Withdrawn Involvement of Endogenous Digitalis-like Compounds in Breast Cancer
Conditions: Breast Neoplasms;   Fibrocystic Disease of Breast;   Mammaplasty
17 Active, not recruiting Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
Condition: Breast Cancer
Interventions: Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: proteomic profiling;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry;   Other: medical chart review;   Procedure: quality-of-life assessment
18 Terminated Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Condition: Breast Cancer
Interventions: Genetic: protein analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: diagnostic laboratory biomarker analysis;   Other: immunohistochemistry staining method;   Other: liquid chromatography;   Other: mass spectrometry;   Procedure: fine-needle aspiration;   Procedure: needle biopsy;   Procedure: radiomammography
19 Active, not recruiting Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
Conditions: Benign Breast Neoplasm;   Ductal Breast Carcinoma In Situ;   Invasive Breast Carcinoma;   Lobular Breast Carcinoma In Situ;   Paget Disease of the Breast;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Docosahexaenoic Acid;   Other: Laboratory Biomarker Analysis;   Other: Placebo
20 Completed An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
Condition: Moderate to Severe Cyclic Mastalgia
Intervention: Drug: Danazol

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.